Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network-Reference-Cited by-同舟云学术

Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network

Published:2020-12-14 Issue:3 Volume:23 Page:411-421
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:J Clin Hypertens

Author:

Kario Kazuomi¹^ORCID,Hoshide Satoshi¹^ORCID,Chia Yook‐Chin²³^ORCID,Buranakitjaroen Peera⁴^ORCID,Siddique Saulat⁵^ORCID,Shin Jinho⁶^ORCID,Turana Yuda⁷^ORCID,Park Sungha⁸^ORCID,Tsoi Kelvin⁹^ORCID,Chen Chen‐Huan¹⁰¹¹¹²^ORCID,Cheng Hao‐Min¹⁰¹¹¹²¹³^ORCID,Fujiwara Takeshi¹^ORCID,Li Yan¹⁴,Huynh Van Minh¹⁵^ORCID,Nagai Michiaki¹⁶^ORCID,Nailes Jennifer¹⁷,Sison Jorge¹⁸,Soenarta Arieska Ann¹⁹,Sogunuru Guru Prasad²⁰²¹^ORCID,Sukonthasarn Apichard²²,Tay Jam Chin²³^ORCID,Teo Boon Wee²⁴^ORCID,Verma Narsingh²⁵^ORCID,Wang Tzung‐Dau²⁶²⁷²⁸^ORCID,Zhang Yuqing²⁹^ORCID,Wang Ji‐Guang³⁰^ORCID

Affiliation:

1. Division of Cardiovascular Medicine Department of Medicine Jichi Medical University School of Medicine Tochigi Japan

2. Department of Medical Sciences School of Healthcare and Medical Sciences Sunway University Bandar Sunway Malaysia

3. Department of Primary Care Medicine Faculty of Medicine University of Malaya Kuala Lumpur Malaysia

4. Division of Hypertension Department of Medicine Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand

5. Punjab Medical Center Lahore Pakistan

6. Faculty of Cardiology Service Hanyang University Medical Center Seoul Korea

7. School of Medicine and Health Sciences Atma Jaya Catholic University of Indonesia Jakarta Indonesia

8. Division of Cardiology Cardiovascular HospitalYonsei Health System Seoul Korea

9. JC School of Public Health and Primary Care The Chinese University of Hong Kong Shatin Hong Kong

10. Institute of Public Health and Community Medicine Research Center National Yang‐Ming University School of Medicine Taipei Taiwan

11. Division of Cardiology Department of Medicine Taipei Veterans General Hospital Taipei Taiwan

12. Faculty of Medicine National Yang‐Ming University School of Medicine Taipei Taiwan

13. Center for Evidence‐based Medicine Department of Medical Education Taipei Veterans General Hospital Taipei Taiwan

14. Centre for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations Shanghai Key Lab of Hypertension Shanghai Institute of HypertensionRuijin HospitalShanghai Jiaotong University School of Medicine Shanghai China

15. Department of Internal Medicine University of Medicine and PharmacyHue University Vietnam

16. Department of Internal Medicine, General Medicine and Cardiology Hiroshima City Asa Hospital Hiroshima Japan

17. Department of Preventive and Community Medicine and Research Institute for Health Sciences University of the East Ramon Magsaysay Memorial Medical Center Inc Quezon City Philippines

18. Section of CardiologyDepartment of MedicineMedical Center Manila Manila Philippines

19. Department of Cardiology and Vascular Medicine Faculty of Medicine University of Indonesia‐National Cardiovascular CenterHarapan Kita Jakarta Indonesia

20. MIOT International Hospital Chennai India

21. College of Medical Sciences Kathmandu University Bharatpur Nepal

22. Cardiology Division Department of Internal Medicine Faculty of Medicine Chiang Mai University Thailand

23. Department of General Medicine Tan Tock Seng Hospital Singapore Singapore

24. Division of Nephrology Department of Medicine Yong Loo Lin School of Medicine Singapore Singapore

25. Department of Physiology King George's Medical University Lucknow India

26. Cardiovascular Center and Division of Cardiology Department of Internal Medicine National Taiwan University Hospital Taipei City Taiwan

27. National Taiwan University Hospital Taipei City Taiwan

28. Division of Hospital Medicine Department of Internal Medicine National Taiwan University Hospital Taipei City Taiwan

29. Divisions of Hypertension and Heart Failure Fu Wai HospitalChinese Academy of Medical Sciences and Peking Union Medical College Beijing China

30. Department of Hypertension Centre for Epidemiological Studies and Clinical Trials the Shanghai Institute of HypertensionShanghai Key Laboratory of HypertensionRuijin HospitalShanghai Jiaotong University School of Medicine Shanghai China

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jch.14128

Reference118 articles.

1. World Health Organization.Global Health Observatory (GHO) data. Raised blood pressure. Available from:http://www.who.int/gho/ncd/risk_factors/blood_pressure_prevalence_text/en/Last accessed: 16 Sep 2020.

2. World Health Organization.A global brief on hypertension. Silent killer global public health crisis. (2013). Available from:https://www.who.int/cardiovascular_diseases/publications/global_brief_hypertension/en/. Last accessed 16 Sep 2020

3. Evidence and Perspectives on the 24-hour Management of Hypertension: Hemodynamic Biomarker-Initiated ‘Anticipation Medicine’ for Zero Cardiovascular Event

4. Consensus Document on Improving Hypertension Management in Asian Patients, Taking Into Account Asian Characteristics

5. Cardiovascular Disease and Risk Factors in Asia

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of wearable home blood pressure monitoring in detecting out-of-office control status;Hypertension Research;2024-01-19

2. Heart rate deceleration and acceleration capacities associated with circadian rhythm of blood pressure in essential hypertension;2024-01-03

3. Inequities in hypertension management;British Journal of General Practice;2023-12-28

4. Simultaneous 24-h ambulatory blood pressure measurement on both arms: a consideration for improving hypertension management;Journal of Hypertension;2023-12-07

5. The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1};Trials;2023-11-28